Drawing for FOAMOSOMES

USPTO serial 86867903

FOAMOSOMES

Reviewed by CopyMark Law Group

Reg. 5157534Status 710
Filing date
Status date
Registration date
Mar 7, 2017
Examiner
FALK, JONATHAN ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with FOAMOSOMES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christie Baty Hudgins

Christie Baty Hudgins Finnegan, Henderson, Farabow, Garrett & Dunner LLP901 New York Avenue, NWWashington, DC 20001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated foamable, foam and mousse skin care preparations for use by babies, infants, children, teenagers and/or adults; non-medicated foamable, foam and mousse care preparations, namely, cosmetics for mucous membranes for use by babies, infants, children, teenagers and/or adults; non-medicated foamable, foam and mousse body cavity care preparations, namely, vaginal, rectal and ear care preparations in the nature of cosmetics for use by babies, infants, children, teenagers and/or adults; non-medicated foamable, foam and mousse skincare preparations primarily composed of cosmetics for cleansing the skin; non-medicated foamable preparations, mousses and foams primarily containing cosmetics, skin conditioners, skin moisturizers, cosmetics featuring pigments, cosmetics featuring dyes, cosmetics featuring antipigmentation agents, cosmetics featuring anti-wrinkle agents, cosmetics featuring anticellulite agents, cosmetics featuring anti-oxidants, cosmetics featuring lubricating agents, cosmetics featuring warming agents, cosmetics featuring cooling agents, cosmetics featuring fragrances, cosmetics featuring free-radical scavengers, cosmetics in the nature of facial cleansersSECTION 8 - CANCELLEDMar 4, 2016
005Foams and foamable pharmaceutical preparation for delivery of prescription and non-prescription therapeutical agents for topical and mucosal prevention and treatment of dermatitis, dermatoses, skin allergy, microbial disorders and diseases, fungal disorders and diseases, viral disorders and diseases, cancer, pigmentation disorders and diseases, skin aging, inflammatory disorders and diseases, vaginal and rectal disorders and diseases, ear and eye disorders, wound and burn healing, skin cancer, hair growth disorders and diseases, alopecia; foams and foamable pharmaceutical preparations, namely, medicated sunscreens, contraceptives, anti-microbial medications, anti-fungals, anti-virals, anti-acne medications, anti-psoriasis preparations, anti-inflammatories, anti-proliferatives for the treatment of skin, eye, ear, body cavity and mucosal diseases, anti-allergic medications, infant skin care in the nature of medicated baby oils, medicated baby ointments, medicated baby creams, medicated baby foams and mousses; medicated foams and foamable pharmaceutical preparations, namely, skin and hair preparation and pharmaceutical preparations for the treatment of eye, ear, body cavity and mucosal membranes, all for use by babies, infants, children, teenagers and adults; foams and foamable pharmaceutical preparations comprising therapeutic agents and/or active pharmaceutical agents, namely, prescription and non prescription pharmaceutical preparations for the treatment of eye, body cavity and mucosal membranes disease and disorders; foams and foamable pharmaceutical preparations for the prevention, treatment, alleviation, relief or amelioration of human disorders and/or diseases, namely, of the skin, eye, ear, body cavity and mucosal membranesSECTION 8 - CANCELLEDMar 4, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 22, 2023C8..CANCELLED SEC. 8 (6-YR)—
Mar 7, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 12, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 14, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 30, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 30, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 7, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 1, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 31, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 27, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 27, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 9, 2017IUAFUSE AMENDMENT FILED—
Jan 9, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 26, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 31, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 31, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 11, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 25, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 25, 2016DOCKASSIGNED TO EXAMINER—
Jan 20, 2016TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jan 20, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 14, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 11, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance